Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ HS3ST2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA531086
Description
Recommended positive controls: A431. Predicted reactivity: Mouse (94%), Rat (94%), Bovine (94%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Heparan sulfate biosynthetic enzymes are key components in generating a myriad of distinct heparan sulfate fine structures that carry out multiple biologic activities. The enzyme encoded by this gene is a member of the heparan sulfate biosynthetic enzyme family. It is a type II integral membrane protein and possesses heparan sulfate glucosaminyl 3-O-sulfotransferase activity. This gene is expressed predominantly in brain and may play a role in the nervous system.
Specifications
HS3ST2 | |
Polyclonal | |
Unconjugated | |
HS3ST2 | |
30ST2; 3OST2; 3-OST-2; h3-OST-2; heparan sulfate (glucosamine) 3-O-sulfotransferase 2; heparan sulfate 3-O-sulfotransferase 2; heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2; Heparan sulfate glucosamine 3-O-sulfotransferase 2; heparan sulfate-glucosamine 3-sulfotransferase 2; heparin-glucosamine 3-O-sulfotransferase; HS3ST2; UNQ2442/PRO5004 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
9956 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q9Y278 | |
HS3ST2 | |
Recombinant fragment corresponding to a region within amino acids 1 and 217 of Human HS3ST2. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction